ONTTF

PINK Oxford Nanopore Technologies Plc
Nov 5, 2026 · 3:23 PM ET DELAYED Market Open

$2.76 ↓ -0.10 (-3.33%) Trading Down from the previous close of $2.86, $0.12 below the day’s high of $2.88

YTD change
+60.47%
vs 20-day SMA
-3.31%
vs 200-day SMA
+42.67%

Price ranges

Previous day
$2.85 $2.94
open $2.90 close $2.86
-$0.04 (-1.55%)
Today
$2.76 $2.88
open $2.80 now $2.76
-$0.04 (-1.43%)
Past week
$2.80 $3.15
from $2.82 now $2.76
-$0.06 (-1.95%)
Past month
$2.61 $3.18
from $2.90 now $2.76
-$0.14 (-4.83%)
This year
$1.27 $3.18
from $1.72 now $2.76
+$1.04 (+60.47%)

Price & Performance

+1.28 (+81.29%) / 6M

$1.31$1.95$2.60$3.24May 5Aug 6Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 53.6% away from all-time highs of $5.95
  • ONTTF is up 60% since the beginning of the year
  • ONTTF is up 58% over the past 12 months
  • ONTTF is down 5% over the past 1 month
  • 0% of all ONTTF investors are betting against ONTTF

ONTTF reads not so good: price sits above one of the two key moving averages, the 12-month move is +63.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 1.69

Balance sheet & scale

IncomeN/A
Revenue$315.1M
Cash$245.3M
Debt$55.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.7B

Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm also develops instruments like GridIONTM and MinIONTM which are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its platform has a broad range of potential applications, including scientific research, personalized medicine, crop science and security and defense. The company was founded by Gordon Sanghera, Spike Willcocks and John Hagan Pryce Bayley in 2005 and is headquartered in Oxford, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $35.10 +1.33%
ARGX argenx SE Sponsored ADR $931.38 +3.36%
ONC BeOne Medicines Ltd. Sponsored ADR $377.78 +6.42%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $12.48 +13.45%
INCY Incyte Corporation $122.85 +4.47%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.